GlassScriptPhysician profile
Donald Michael Riddle
NPI 1861476061
$812.35
in general payments reported to CMS, 2019-2025
12 companies · $90.78 in 2025
The $90.78 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $23.97 · 2021: $95.21 · 2022: $180 · 2023: $167 · 2024: $119 · 2025: $90.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $218.71 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $166.27 | 2021-2025 | |
| Ironshore Pharmaceuticals INC. | $91.55 | 2019-2024 | |
| Pfizer INC. | $90.58 | 2021-2025 | |
| Aytu Biopharma, INC. | $79.47 | 2022-2023 | Karbinal |
| Takeda Pharmaceuticals U.S.A., INC. | $43.15 | 2019-2021 | |
| Tris Pharma INC | $27.45 | 2019 | |
| Cranial Technologies, INC | $26.75 | 2019 | |
| Seqirus USA INC | $19.98 | 2022 | |
| Organon LLC | $18.46 | 2025 | |
| Shire North American Group INC | $15.87 | 2019 | |
| Quidel Corporation | $14.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Riddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.